Malin received a $113 million (€95 million) up-front payment last month as French drugs giant Sanofi bought Kymab. Image: iStock

Malin Corporation revealed on Thursday it spent almost €4.8 million buying back some of its own shares this week at €6 each, a little over a month aft(...)

Poseida, in which Malin holds a 15% stake, plunged in August after a safety trial for one of its early-stage pipeline products, a prostate cancer drug, was  halted following a patient death. Photograph: Joe Raedle/Getty

Malin Corp, the Dublin-listed life sciences investment firm, is on track to return about €250 million of cash to shareholders from assets sales in the(...)